NIH Awards Immuven $1.68 Million for MRSA Therapeutics

  ImmuVen (www.immuven.com) was awarded a Phase II Small Business Innovation Research (SBIR) grant totaling $1.68 million from the National Institute for … Continue reading NIH Awards Immuven $1.68 Million for MRSA Therapeutics